Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
28,406,191
-
Total 13F shares
-
1,877,652
-
Share change
-
+1,876,752
-
Total reported value
-
$17,728,000
-
Put/Call ratio
-
34%
-
Price per share
-
$9.44
-
Number of holders
-
20
-
Value change
-
+$17,720,019
-
Number of buys
-
19
Institutional Holders of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) as of Q2 2019
As of 30 Jun 2019,
Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,877,652 shares.
The largest 10 holders included
ARK Investment Management LLC, HIGHLINE CAPITAL MANAGEMENT, L.P., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., ROYCE & ASSOCIATES LP, Creative Planning, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Diametric Capital, LP, and UNITED CAPITAL FINANCIAL ADVISERS, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.